Literature DB >> 24880984

Successful cetuximab therapy after failure of panitumumab rechallenge in a patient with metastatic colorectal cancer: restoration of drug sensitivity after anti-EGFR monoclonal antibody-free interval.

Akito Hata1, Nobuyuki Katakami, Naoto Kitajima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24880984     DOI： 10.1007/s12029-014-9624-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  2 in total

1.  Panitumumab rechallenge in chemorefractory patients with metastatic colorectal cancer.

Authors:  Akito Hata; Nobuyuki Katakami; Shiro Fujita; Kento Takatori; Aya Horai; Naoto Kitajima; Kazuki Terashima
Journal:  J Gastrointest Cancer       Date:  2013-12

2.  Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Authors:  D Santini; B Vincenzi; R Addeo; C Garufi; G Masi; M Scartozzi; A Mancuso; A M Frezza; O Venditti; M Imperatori; G Schiavon; G Bronte; G Cicero; F Recine; E Maiello; S Cascinu; A Russo; A Falcone; G Tonini
Journal:  Ann Oncol       Date:  2012-03-05       Impact factor: 32.976
  2 in total
  4 in total

Review 1.  Integrating liquid biopsies into the management of cancer.

Authors:  Giulia Siravegna; Silvia Marsoni; Salvatore Siena; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2017-03-02       Impact factor: 66.675

Review 2.  Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09.

Authors:  Akihito Tsuji; Masato Nakamura; Takanori Watanabe; Dai Manaka; Hiroshi Matsuoka; Masato Kataoka; Masahiro Takeuchi; Wataru Ichikawa; Masashi Fujii
Journal:  Target Oncol       Date:  2021-10-31       Impact factor: 4.864

Review 3.  Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.

Authors:  Richard M Goldberg; Clara Montagut; Zev A Wainberg; Philippe Ronga; François Audhuy; Julien Taieb; Sebastian Stintzing; Salvatore Siena; Daniele Santini
Journal:  ESMO Open       Date:  2018-05-05

4.  Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation.

Authors:  Tomokazu Ohishi; Yukinari Kato; Mika K Kaneko; Shun-Ichi Ohba; Hiroyuki Inoue; Akiko Harakawa; Manabu Kawada
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.